Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Candrina

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Medicina (Florence, Italy)|April 1, 1988
[Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly]R Candrina
Recenti Progressi in Medicina|January 1, 1991
Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administrationR Candrina
Diabetes Research and Clinical Practice|September 1, 1986
Re: Control of glucose homeostasis in diabetic surgical patients by means of continuous i.v. insulin infusionR Candrina
Recenti Progressi in Medicina|January 1, 1994
Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenomaR Candrina
Israel Journal of Medical Sciences|January 1, 1988
Development of type II autoimmune polyglandular syndrome in a patient with idiopathic thrombocytopenic purpuraR Candrina, A Giustina
JAMA|December 5, 1986
Development of acromegaly after pituitary apoplexyR Candrina, G Giustina
Clinical Endocrinology|August 1, 1987
Effects of SMS 201-995 in non-insulin-dependent diabetesR Candrina, G Giustina
Recenti Progressi in Medicina|September 1, 1989
[Treatment of hypophyseal prolactin-secreting macroadenomas]R Candrina, M Tosoni
The American Journal of the Medical Sciences|July 1, 1990
Iodine-induced subacute thyroiditis with thyrotoxicosis presenting as fever of unknown originR Candrina, G Giustina
Journal of Endocrinological Investigation|July 1, 1988
Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal profiles in insulin-treated type II diabetic patientsR Candrina, G Giustina
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Medicina (Florence, Italy)|April 1, 1988
[Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly]R Candrina
Recenti Progressi in Medicina|January 1, 1991
Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administrationR Candrina
Diabetes Research and Clinical Practice|September 1, 1986
Re: Control of glucose homeostasis in diabetic surgical patients by means of continuous i.v. insulin infusionR Candrina
Recenti Progressi in Medicina|January 1, 1994
Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenomaR Candrina
Israel Journal of Medical Sciences|January 1, 1988
Development of type II autoimmune polyglandular syndrome in a patient with idiopathic thrombocytopenic purpuraR Candrina, A Giustina
JAMA|December 5, 1986
Development of acromegaly after pituitary apoplexyR Candrina, G Giustina
Clinical Endocrinology|August 1, 1987
Effects of SMS 201-995 in non-insulin-dependent diabetesR Candrina, G Giustina
Recenti Progressi in Medicina|September 1, 1989
[Treatment of hypophyseal prolactin-secreting macroadenomas]R Candrina, M Tosoni
The American Journal of the Medical Sciences|July 1, 1990
Iodine-induced subacute thyroiditis with thyrotoxicosis presenting as fever of unknown originR Candrina, G Giustina
Journal of Endocrinological Investigation|July 1, 1988
Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal profiles in insulin-treated type II diabetic patientsR Candrina, G Giustina
Pageof 4